Skip to content

Canadian e-Platform to Promote Behavioral Self-Management in Chronic Heart Failure: CHF-CePPORT

Canadian e-Platform to Promote Behavioral Self-Management in Chronic Heart Failure: CHF-CePPORT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01864369
Acronym
CHF-CePPORT
Enrollment
248
Registered
2013-05-29
Start date
2013-09-30
Completion date
2018-07-31
Last updated
2021-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, e-counseling, quality of life, self-care

Brief summary

Chronic Heart Failure (CHF) is a growing public health issue in Canada. Hospital re-admission within 1-year after diagnosis is 25-40%, and the 5-year rate of CHF death is 50%. Counseling by multidisciplinary health care teams helps CHF patients to improve self-care behaviors (for medications, diet, exercise, smoking cessation and symptom monitoring), and this reduces the rate of death and CHF hospitalization. In the absence of intervention, patient adherence to these behaviors is below recommended standards and quality of life among CHF patients becomes progressively compromised. A major challenge is to make self-care counseling available without overtaxing health care resources. This year multicenter clinical trial will establish and evaluate a Canadian e-platform that provides multidisciplinary e-counseling to help patients with CHF to initiate and maintain recommended self-care behaviors. The investigators will recruit 298 CHF patients in Toronto, Montreal and Vancouver. The investigators hypothesize that a 12-month program of e-Counseling + Usual Care versus general eInfo + Usual Care will improve quality of life, self-care behaviors, program engagement, and heart health. This proposal is based upon previous clinical trials in CHF, e-health and preventive lifestyle counseling by our team. The novel contribution of this research is that it will establish an infrastructure for a pan-Canadian e-platform in preventive e-counseling for CHF. A key feature of this proposal is that our multidisciplinary team will work with professional heart health organizations to share our findings and e-health resources with the public and other health care professionals in Canada, which will help to galvanize research and clinical work in eCounseling. Our clinical trial will strengthen eCounseling services in order to improve the quality of life of patients with CHF.

Interventions

BEHAVIORALeCounseling + Usual Care

This intervention will use film vignettes and interactive web pages. The e-counseling messages will promote: (i) validation of the subject's stage of readiness for behavior change, (ii) collaborative participation by means of subject-selected menus, (iii) reinforcement of change talk to resolve ambivalence, (iv) use of self-help information and e-tools for self-monitoring of targeted self-care behaviors, and (v) development of cognitive-behavioral skills to build and strengthen efficacy. Messages will be proactively sent to Controls according to the following schedule: weekly for months 1 to 4, bi-weekly for months 5 to 8, and monthly for months 9 to 12.

Sponsors

Heart and Stroke Foundation of Ontario
CollaboratorOTHER
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male and female patients 18 years of age who are diagnosed with heart failure with reduced ejection fraction (systolic HF) corresponding to New York Heart Association Class II-III for 3 months prior to enrolment; 2. documentation of LVEF 40%; 3. subject has access to a personal computer;

Exclusion criteria

1. Documentation at enrolment of renal failure, significant liver disease or poorly controlled diabetes mellitus; 2. persistent systolic or diastolic hypertension \[systolic \> 170 mmHg or diastolic \> 100 mmHg despite antihypertensive therapy; 3. CHF secondary to cardiovascular co-morbidities/procedures; 4. previous heart transplant or wait listed for heart transplant at time of enrolment

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life: Kansas City Cardiomyopathy Questionnaire12 monthsThe primary outcome in CHF-CePPORT is quality of life, as measured by the number of subjects who demonstrate a clinically meaningful increase of ≥5 points on the summary index of the Kansas City Cardiomyopathy Questionnaire (KCCQ).

Secondary

MeasureTime frameDescription
Program engagement and usability4- and 12- monthsActive engagement with digital platform: total time, # logons, % material accessed
Behavioral,functional and clinical outcomes4- and 12- monthsQuality of life: number of subjects with KCCQ ≥5 points
Behavioral, clinical and funcitonal outcomes4 and 12- monthsAdherence to daily dietary guidelines for fruit and vegetable intake: NIH/NCI Diet History Questionnaire.
Behavioral, functional and clinical outcomes4- and 12- monthsPhysical activity: 4-day step count with Triaxial Accelerometer.
Clinical and functional assesments.12-monthsFunctional capacity: 6-minute walk test.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026